Cancer Immunotherapy
See How We Impact All Cancers

Immunotherapy has the potential to treat almost any type of cancer. Learn how we are making this a reality for more patients sooner.

Learn More
Our Strategy & Impact
Meet Our Community

Cancer patients, donors, scientists, and other supporters all stand behind the Cancer Research Institute. Read their stories and learn about what motivates each of us to keep fighting against cancer.

Meet Our Community
Get Involved
June is Cancer Immunotherapy Awareness Month!

Show your support for CRI and cancer immunotherapy research by wearing white on June 7, attending free webinars, or shopping at 1-800-FLOWERS.COM.

Show ydJune is Cancer Immunotherapy Awareness Month! You can show your support for CRI by wearing white on June 7, attend free webinars, or shop at 1-800-flowers.com with proceeds benefitting our fight with white campaign. - See more at: http://www.cancerresearch.org/get-involved/cri-events#sthash.ezur25wt.dpuf

Join the Fight with White
Giving to CRI
Honor a Loved One's Memory

We gratefully accept donations made in memory or in honor of a loved one. Your gift will be acknowledged to whomever you specify.

Make a Gift in Memory or Honor of Someone

Grants & Programs
Innovating to Keep Progress Moving Foward

Numerous challenges can derail progress in finding new immune-based cancer treatments. We're solving some of the biggest challenges, keeping promising new immunotherapies on the fast track to patients.

Learn How We Fast Track Immunotherapies
News & Publications
Stories of Hope in Their Own Words

Cancer patients are now beginning to benefit from advances in cancer immunotherapy. Watch this story of hope and survival, and be inspired to help us conquer cancer.

This Is Only Just the Beginning
About CRI
Meet the Minds that Power Our Work

Browse our directory of scientific leaders who volunteer their time and expertise to help ensure that we fund the most innovative and promising research possible.

Meet the Scientific Leadership at CRI

Grants & Programs

Membership

At this time of change and progress in the field of cancer immunology, members of the Cancer Immunotherapy Consortium (CIC) create a single and powerful voice within the biomedical research community to address the networking, clinical, and regulatory needs of academic scientists, corporations, and organizations working in this promising area of biomedicine. CIC members provide data-driven solutions to scientific and developmental challenges and help to validate and accelerate the development and approval of effective cancer immunotherapies.

A growing list of more than 110 organizations belong to the Cancer Immunotherapy Consortium, including many of the world's leading biotech and biopharmaceutical companies and academic research universities and medical centers.